Stocks · Healthcare · Medical - Devices
InfuSystem Holdings, Inc. INFU
$13.16 +2.65% Close, Oct 2, 2026 · AMEX · Market cap $265.6M
High qualityStrong trendInexpensive vs sector
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $0.41, up 74.0% year over year.
- Earnings beat analyst estimates in each of the last 6 quarters (average surprise over the last four: +37.1%).
- The stock is in an uptrend: above its 200-day average for 43 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 34%
- EPS growth (TTM, YoY)Top 18%
- FCF growth (TTM, YoY)Top 32%
- Revenue growth, 3-year CAGRBottom 47%
- Revenue growth accelerationBottom 41%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 13%
- Gross marginBottom 43%
- Operating marginTop 28%
- Cash conversion (OCF / net income)Top 22%
- Accruals (lower is better)Top 22%
- Net debt / EBITDA (lower is better)Top 46%
- Interest coverTop 9%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 18%
- Free-cash-flow yieldTop 12%
- EBITDA / enterprise valueTop 13%
- Sales / enterprise valueTop 25%
- P/E vs own 5-year history (lower is better)Top 35%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 47%
- 6-month returnTop 24%
- 1-year return vs S&P 500Top 37%
- Distance from 52-week highTop 1%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 16%
- Consecutive EPS beatsTop 12%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetBottom 22%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 30%
- Maximum drawdown, 3 yearsTop 30%
- Beta vs S&P 500 (lower is better)Bottom 21%
- Net debt / EBITDA (lower is better)Top 46%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 3.5% | 2.5% | ↓ |
| EPS growth (YoY) | 162.6% | 74.0% | ↓ |
| Gross margin | 54.5% | 57.5% | ↑ |
| Operating margin | 7.3% | 9.3% | ↑ |
| FCF margin | 9.6% | 13.3% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 2.5% | 3.5% | ↓ | Bottom 34% |
| EPS growth (TTM, YoY) | 74.0% | 162.6% | ↓ | Top 18% |
| Gross margin | 57.5% | 54.5% | ↑ | Bottom 43% |
| Operating margin | 9.3% | 7.3% | ↑ | Top 28% |
| Net margin | 6.0% | 3.6% | ↑ | — |
| Free-cash-flow margin | 13.3% | 9.6% | ↑ | — |
| Return on invested capital | 11.3% | — | Top 13% | |
| Revenue growth, 3-year CAGR | 9.3% | — | Bottom 47% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 2.74×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -15.2%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +8.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.98×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 18.4×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 3.35%
- Shareholder yield
- 3.35%
- Share count change, 1 year
- -0.6%
- Share count change, 3-year CAGR
- -1.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 6
- Beats in the last 8 reports
- 7 of 8
- Average EPS surprise, last 4
- +37.1%
- Average 2-day reaction, last 8
- +5.0%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $15.00
- Target vs current price
- +14.0%
- Analysts with a rating
- 4
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +42.9% | +33.6% | +31.5% | +31.8% | — |
| May 7, 2026 | +25.0% | -11.5% | -19.0% | -10.1% | -9.1% |
| Feb 24, 2026 | +42.9% | +13.5% | +22.6% | +26.6% | +27.6% |
| Nov 4, 2025 | +37.5% | -9.0% | -3.0% | -13.7% | -20.6% |
| Aug 5, 2025 | +300.0% | +3.8% | +47.0% | +80.9% | +78.6% |
| May 8, 2025 | +66.7% | +15.2% | +20.6% | +24.8% | +23.2% |
| Mar 4, 2025 | -50.0% | -10.9% | -22.3% | -25.9% | -28.1% |
| Nov 7, 2024 | +33.3% | +5.2% | +27.9% | +26.4% | +17.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.15 | $0.11 | +42.9% | $36.9M |
| May 7, 2026 | $0.05 | $0.04 | +25.0% | $33.7M |
| Feb 24, 2026 | $0.10 | $0.07 | +42.9% | $36.2M |
| Nov 4, 2025 | $0.11 | $0.08 | +37.5% | $36.5M |
| Aug 5, 2025 | $0.12 | $0.03 | +300.0% | $36.0M |
| May 8, 2025 | -$0.01 | -$0.03 | +66.7% | $34.7M |
| Mar 4, 2025 | $0.04 | $0.08 | -50.0% | $33.8M |
| Nov 7, 2024 | $0.08 | $0.06 | +33.3% | $35.3M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 32.5× | 88.8× | 28th | Top 18% |
| P/E (forward) | 28.6× | — | — | — |
| EV / EBITDA | 12.6× | — | — | Top 13% |
| EV / Sales | 2.01× | — | — | Top 25% |
| Free-cash-flow yield | 7.19% | — | — | Top 12% |
| Earnings yield | 3.08% | — | — | Top 18% |
P/E over the past five years
Range 21.1× – 464.0× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +28.1%
- Earnings per share growth (TTM)
- +74.0%
- Change in P/E multiple
- +16.7%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 43
- Days above the 200-day average
- 43
- 50-day average slope (20 days)
- +11.7%
- 200-day average slope (20 days)
- +3.5%
- Distance from 50-day average
- +10.1%
- Distance from 200-day average
- +33.7%
- RSI (14)
- 66.2
- Relative volume
- 0.87×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 68.2%
- Volatility vs own 5-year history
- 91th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.77
- Correlation with S&P 500
- 0.40
- Current drawdown from 1-year high
- +0.0%
- Maximum drawdown, 3 years
- -56.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| May 3, 2021 | May 6, 2025 | -79.5% | 1007 days | Not yet recovered |
| Feb 16, 2021 | Feb 26, 2021 | -13.4% | 8 days | 10 days (Mar 12, 2021) |
| Dec 22, 2020 | Jan 14, 2021 | -12.8% | 15 days | 19 days (Feb 11, 2021) |
| Sep 25, 2020 | Oct 30, 2020 | -10.8% | 25 days | 10 days (Nov 13, 2020) |
| Mar 17, 2021 | Mar 29, 2021 | -10.7% | 8 days | 20 days (Apr 27, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $265.6M
- P/E (TTM)
- 32.5
- EPS, diluted (TTM)
- $0.41
- Revenue (TTM)
- $143.3M
- 52-week range
- $7.29 – $13.20
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $102.4M | $109.9M | $125.8M | $134.9M | $143.4M |
| Gross profit | $58.5M | $60.6M | $63.1M | $70.4M | $80.3M |
| Operating income | $2.8M | $1.7M | $4.1M | $6.9M | $11.9M |
| Net income | $1.4M | $18,000 | $872,000 | $2.3M | $6.6M |
| EPS (diluted) | $0.06 | $0.00 | $0.04 | $0.11 | $0.31 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.3M | $33.8M | $34.7M | $36.0M | $36.5M | $36.2M | $33.7M | $36.9M |
| Net income | $1.8M | $933,000 | -$267,000 | $2.6M | $2.3M | $2.0M | $1.0M | $3.2M |
| EPS (diluted) | $0.08 | $0.04 | -$0.01 | $0.12 | $0.11 | $0.10 | $0.05 | $0.15 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $18.3M | $17.5M | $11.2M | $20.5M | $24.4M |
| Capital expenditure | -$16.7M | -$15.1M | -$11.1M | -$17.8M | -$8.7M |
| Free cash flow | $1.7M | $2.4M | $106,000 | $2.6M | $15.7M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$1.7M | -$6.7M | -$1.3M | -$2.0M | -$10.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $964,000
- Total assets
- $97.7M
- Total liabilities
- $38.6M
- Total debt
- $23.3M
- Net debt
- $22.3M
- Shareholders’ equity
- $59.1M
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 812,365
- Days to cover
- 7.09
- Change vs previous report
- +7.6%
FINRA short interest, settlement date Sep 15, 2026.